Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03353610 · ClinicalTrials.gov registry record

The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.

A clinical trial, sponsored by Milestone Pharmaceuticals.

Terminated
Registry status
354
Enrollment target

NCT03353610 is a clinical trial that was terminated before completion, run by Milestone Pharmaceuticals. The registered enrollment target is 354 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03353610 was terminated before completion, sponsored by Milestone Pharmaceuticals.

TERMINATED
Registry status
354 participants
Enrollment target

Study Summary

Paroxysmal supraventricular tachycardia (PSVT) is a sporadic, sudden, and recurring tachycardia that is caused by an altered electrical conductivity in the heart. It causes palpitations and a rapid heart rate, which may induce fear in the patient and negatively impact the patient's quality of life. Therefore, most patients experience not only physical symptoms of PSVT, but also dramatic psychological burdens. As PSVT drug development efforts advance, it has become increasingly important to document the impact of PSVT in a systematic way, in terms of the disease natural history and clinical characteristics of PSVT episodes, as well as the psychological impact of the condition as reported by patients over time. In order to meet the needs for ongoing, systematic data collection on PSVT, a multinational registry, The PSVT Place Registry (www.PSVTPlaceRegistry.com), is being implemented and will be initially comprised of data entered directly by patients. The long-term registry is designed with a participant-focused approach to enable continuity of data collection and minimization of impact from changes of participants' health care providers. The registry may be expanded at a later time to include physician-reported data. The information from the registry is planned to be a resource for participants with PSVT, their families and support networks, their doctors, and the research community to better understand PSVT-related symptoms and awareness, PSVT diagnoses, patient self-management, medical treatments for PSVT, and impact of PSVT on quality of life from the patient perspective.

Trial Details

FieldValue
Enrollment Target 354 participants
Start Date 2017-10-16
Est. Completion 2020-03-16

Sponsor

Milestone Pharmaceuticals

7 total trials

What the Registry Record Tells You About NCT03353610

The ClinicalTrials.gov registry entry for NCT03353610 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milestone Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03353610 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03353610 about?

NCT03353610 is a clinical study titled "The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.". Paroxysmal supraventricular tachycardia (PSVT) is a sporadic, sudden, and recurring tachycardia that is caused by an altered electrical conductivity in the heart. It causes palpitations and a rapid heart rate, which may induce fear in the patient and negatively impact the patient's quality of life. ...

What is the current status of trial NCT03353610?

This trial is currently terminated. The enrollment target is 354 participants. The study started on 2017-10-16. Estimated completion is 2020-03-16.

Who is sponsoring clinical trial NCT03353610?

This trial is sponsored by Milestone Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.